← Leaderboards
Nicholas M. Pajewski
Duke University
$4,423,163
Attributed
$9,426,854
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,426,854 · 2
By mechanism
R01$7,505,536 · 1
U24$1,921,318 · 1
Top collaborators
- Michael J Blaha4 shared
- Melissa Daubert4 shared
Most similar at Duke University
Same institution · by research overlap
- Alessandro Bartolomucci$5,344,628
- Kishore M Gadde$5,984,050
- Melissa Daubert$2,501,845
- Deborah M Muoio$18,719,990
- Anthony J Viera$4,111,113
Others in their field
Other Emerging Leaders on “Lipids”
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Bradley G Hammill · Duke University$15,773,864
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
- Robert J Woods · Virginia Polytechnic Institute And State University$12,760,318
- Norbert Pardi · University Of Pennsylvania$12,463,043
- Vaia Lida Chatzi · University Of Southern California$9,466,057
Research focus
LipidsCardiovascular Disorder RiskCardiacAtherosclerosisPlacebosInfrastructureParticipantMortalityWeightAdultCardiovascular DiseasesRisk FactorsLifeRandomized TrialBehavioral StudyCardiometabolic RiskCardiometabolismBasal Metabolic RateBody Weight DecreasedClinical Research SiteBody Weight ChangesBody WeightBody Mass IndexBlood Pressure
Grant awards (9)
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study$1,058,459
R01 · FY2025 · HL
2/2, Data Coordinating Center for the Long-term Effectiveness of the Anti-obesity medication Phentermine: the LEAP Trial$432,054
U24 · FY2025 · HL · contact PI
2/2, Data Coordinating Center for the Long-term Effectiveness of the Anti-obesity medication Phentermine: the LEAP Trial$420,848
U24 · FY2024 · HL · contact PI
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study$2,244,161
R01 · FY2023 · HL
2/2, Data Coordinating Center for the Long-term Effectiveness of the Anti-obesity medication Phentermine: the LEAP Trial$309,250
U24 · FY2023 · HL · contact PI
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study$2,921,424
R01 · FY2022 · HL
2/2, Data Coordinating Center for the Long-term Effectiveness of the Anti-obesity medication Phentermine: the LEAP Trial$309,545
U24 · FY2022 · HL · contact PI
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study$1,281,492
R01 · FY2021 · HL
2/2, Data Coordinating Center for the Long-term Effectiveness of the Anti-obesity medication Phentermine: the LEAP Trial$449,621
U24 · FY2021 · HL · contact PI